University of Texas Health Science Center at San Antonio: Frequently Asked Questions - Novavax Investigational COVID-19 Vaccine Trial
January 08, 2021
January 08, 2021
SAN ANTONIO, Texas, Jan. 8 -- The University of Texas Health Science Center at San Antonio issued the following news release:
Our South Texas community will be contributing to an investigational vaccine clinical trial that may help end the COVID-19 pandemic. Dr. Barbara Taylor, the principal investigator for the local study site, answers questions about the importance of the program and how it will be conducted.
Dr. Taylor is an associate professor of infectious disease . . .
Our South Texas community will be contributing to an investigational vaccine clinical trial that may help end the COVID-19 pandemic. Dr. Barbara Taylor, the principal investigator for the local study site, answers questions about the importance of the program and how it will be conducted.
Dr. Taylor is an associate professor of infectious disease . . .